At the Veeva R&D and Quality Summit in Boston, leading biopharma companies like Eli Lilly, Pfizer, and Sanofi shared innovations in AI, cloud platforms, and connected trials to accelerate drug development and improve quality. Highlights include Eli Lilly's AI to boost productivity, UCB's automated safety case processing, and Pfizer's cloud-based lab system pilot. The event gathers over 2,500 life sciences professionals to explore new tech-driven workflows shaping the future of medicine development and manufacturing. This collaboration signals a shift toward more efficient, patient-focused clinical trials and quality management.
Veeva Systems trades at USD 282.88 on Pluang, up 0.13% as of Oct 08, 2026 18:11 WIB. Eli Lilly shares are priced at USD 1,193.32 with a 0.39% gain, while Pfizer is slightly down 0.07% at USD 27.98. Sanofi is at USD 39.84, down 0.90%, reflecting mixed investor sentiment among these biopharma leaders during the summit.
